(Q44361280)

2 December 2017

1 reference

title

Modulation of disease by superantigens (English)

1 reference

2 December 2017

Torres BA

1

1 reference

PubMed ID

9722924

2 December 2017

Johnson HM

series ordinal

2

1 reference

2 December 2017

1 August 1998

1 reference

Current Opinion in Immunology

2 December 2017

1 reference

2 December 2017

10

1 reference

2 December 2017

4

1 reference

2 December 2017

465-470

1 reference

The I-A beta b region (65-85) is a binding site for the superantigen, staphylococcal enterotoxin A

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Superantigens interact with MHC class II molecules outside of the antigen groove.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

V beta-specific stimulation of human T cells by staphylococcal toxins.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Type I interferon inhibition of superantigen stimulation: implications for treatment of superantigen-associated disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Oral feeding of interferon tau can prevent the acute and chronic relapsing forms of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

IFN-tau suppresses both the autoreactive humoral and cellular immune responses and induces stable remission in mice with chronic experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Evidence for the effects of a superantigen in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

The repertoire of rheumatoid factor-producing B cells in normal subjects and patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

The model of arthritis induced by superantigen in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Role of superantigens in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Reiter's Disease following Yersinia Enterocolitica Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Evidence for a viral superantigen in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Superantigen related to rabies.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

An Epstein-Barr virus-associated superantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

HIV encodes for its own CD4 T-cell superantigen mitogen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Enhanced HIV-1 replication in V beta 12 T cells due to human cytomegalovirus in monocytes: evidence for a putative herpesvirus superantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Superantigens and retroviral infection: insights from mouse mammary tumor virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

V beta activation by HIV Nef protein: detection by a simple amplification procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Characterization of Nef-induced CD4 T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Superantigens and their potential role in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Restricted T-cell receptor V beta gene usage in the skin of patients with guttate and chronic plaque psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

Evidence for a superantigen in the pathogenesis of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980122-2

7 January 2021

10.1016/S0952-7915(98)80122-2

Identifiers

DOI

1 reference

release_zcddia7z5fdrzmspitqiqlgjiu

2 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zcddia7z5fdrzmspitqiqlgjiu

24 November 2022

mapped directly with Wikidata item

PubMed ID

9722924

1 reference

PubMed ID

9722924